Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 EUR | -1.87% | -1.50% | -7.42% |
2023 | Biokarpet S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Biokarpet S.A.(ATSE:BIOKA) added to ATHEX Composite Index | CI |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 7.052 | 12.95 | 21.71 | 20.75 | 39.82 | 37.66 |
Enterprise Value (EV) 1 | 79.43 | 84.28 | 96.37 | 109.8 | 133.7 | 135.5 |
P/E ratio | -7.72 x | 75.9 x | 17.5 x | 94.8 x | 9.47 x | 4.19 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.07 x | 0.11 x | 0.17 x | 0.17 x | 0.21 x | 0.16 x |
EV / Revenue | 0.76 x | 0.71 x | 0.77 x | 0.89 x | 0.71 x | 0.59 x |
EV / EBITDA | 15 x | 12.3 x | 12 x | 14.6 x | 11.1 x | 7.54 x |
EV / FCF | 537 x | 32.2 x | 57.1 x | -8.09 x | -27.8 x | -15.4 x |
FCF Yield | 0.19% | 3.1% | 1.75% | -12.4% | -3.6% | -6.5% |
Price to Book | 0.23 x | 0.46 x | 0.75 x | 0.71 x | 1.19 x | 0.85 x |
Nbr of stocks (in thousands) | 23,987 | 23,987 | 23,987 | 23,987 | 23,987 | 23,987 |
Reference price 2 | 0.2940 | 0.5400 | 0.9050 | 0.8650 | 1.660 | 1.570 |
Announcement Date | 30/04/18 | 24/04/19 | 27/05/20 | 23/04/21 | 29/04/22 | 26/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 105.1 | 119.4 | 125.8 | 123.2 | 187.3 | 231.2 |
EBITDA 1 | 5.303 | 6.869 | 8.047 | 7.517 | 12.08 | 17.97 |
EBIT 1 | 1.62 | 3.151 | 4.552 | 3.492 | 7.703 | 13.47 |
Operating Margin | 1.54% | 2.64% | 3.62% | 2.83% | 4.11% | 5.82% |
Earnings before Tax (EBT) 1 | -1.016 | -0.2691 | 1.955 | 0.763 | 5.018 | 10.84 |
Net income 1 | -0.9137 | 0.1707 | 1.239 | 0.2188 | 4.206 | 8.995 |
Net margin | -0.87% | 0.14% | 0.99% | 0.18% | 2.25% | 3.89% |
EPS 2 | -0.0381 | 0.007115 | 0.0517 | 0.009121 | 0.1753 | 0.3750 |
Free Cash Flow 1 | 0.148 | 2.614 | 1.686 | -13.57 | -4.808 | -8.814 |
FCF margin | 0.14% | 2.19% | 1.34% | -11.01% | -2.57% | -3.81% |
FCF Conversion (EBITDA) | 2.79% | 38.05% | 20.96% | - | - | - |
FCF Conversion (Net income) | - | 1,531.39% | 136.06% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 30/04/18 | 24/04/19 | 27/05/20 | 23/04/21 | 29/04/22 | 26/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 72.4 | 71.3 | 74.7 | 89 | 93.9 | 97.9 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 13.65 x | 10.38 x | 9.279 x | 11.85 x | 7.774 x | 5.446 x |
Free Cash Flow 1 | 0.15 | 2.61 | 1.69 | -13.6 | -4.81 | -8.81 |
ROE (net income / shareholders' equity) | -2.81% | 0.64% | 4.38% | 0.8% | 13.3% | 23% |
ROA (Net income/ Total Assets) | 0.8% | 1.56% | 2.19% | 1.56% | 3% | 4.59% |
Assets 1 | -114.6 | 10.92 | 56.61 | 14.04 | 140 | 196 |
Book Value Per Share 2 | 1.300 | 1.170 | 1.210 | 1.210 | 1.400 | 1.860 |
Cash Flow per Share 2 | 0.1300 | 0.1200 | 0.0900 | 0.1300 | 0.2000 | 0.1500 |
Capex 1 | 2.72 | 4.08 | 6.53 | 8.24 | 12 | 10.3 |
Capex / Sales | 2.59% | 3.41% | 5.19% | 6.69% | 6.41% | 4.46% |
Announcement Date | 30/04/18 | 24/04/19 | 27/05/20 | 23/04/21 | 29/04/22 | 26/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-7.42% | 69.32M | |
+11.85% | 7.39B | |
+2.55% | 3.29B | |
+23.06% | 905M | |
+12.83% | 408M | |
+16.32% | 277M | |
-2.51% | 161M | |
+8.54% | 130M | |
-63.02% | 92.94M | |
0.00% | 94.24M |
- Stock Market
- Equities
- BIOKA Stock
- Financials Biokarpet S.A.